Sponsor:
National Institutes of Health
UI Contact:
Updated Date:
May 7, 2019
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices, program announcements, and requests for applications:
Notices
- Request for Information (RFI) Regarding Tissue Source Options for Generating Human Immune System (HIS) Mice
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
National Institute of Allergy and Infectious Diseases - Notice of the Publication of Revised NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules
National Institutes of Health - Request for Information (RFI): Inviting comments and suggestions for the development of the NIA Longitudinal Rat Resource to study neural and behavioral trajectories of successful cognitive aging
National Institute on Aging - Notice of Correction to NOT-AG-19-007, "Notice of Special Interest: High-Priority Research Topics for PAR-19-071"
National Institute on Aging - Notice of Intent to Publish: Funding Opportunity Announcement for Human Immune-Representing Oncology Models for Immuno-Oncology Research (R33 Clinical Trial Optional)
National Cancer Institute - Notice of NIDCR's Participation in PAR-19-193 "Microbial-based Cancer Therapy-Bugs as Drugs (R01- Clinical Trial Not Allowed)"
National Institute of Dental and Craniofacial Research - Notice of NIDCR's Participation in PAR-19-194 "Microbial-based Cancer Therapy-Bugs as Drugs (R21- Clinical Trial Not Allowed)"
National Institute of Dental and Craniofacial Research - Notice of Information: NIH In-Kind Participation in Belmont Forum Collaborative Research Action (CRA) on Climate, Environment and Health (CEH)
National Institute of Environmental Health Sciences
John E. Fogarty International Center - Notice of Change in Candidate Eligibility for PAR-18-726 "NEI Institutional Mentored Physician Scientist Award (K12 Clinical Trial Optional)"
National Eye Institute - Notice of Change in the NEI K23 Eligibility Requirements
National Eye Institute - Notice of Change in the NEI K08 Eligibility Requirements
National Eye Institute - Request for Information: Research Plan on Rehabilitation
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute on Deafness and Other Communication Disorders
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Neurological Disorders and Stroke
National Institute of Nursing Research - Notice of Change to Key Date(s) for RFA-HD-20-004 "Medical Rehabilitation Research Resource (P2C Clinical Trial Optional)"
Eunice Kennedy Shriver National Institute of Child Health and Human Development - Pre-Submission Technical Assistance Webinar and Frequently Asked Questions for RFA-HL-20-005 "Late-Stage Implementation Research Addressing Hypertension in Low- and Middle-Income Countries: Scaling Up Proven-Effective Interventions (UG3/UH3 CT Optional)"
National Heart, Lung, and Blood Institute - Notice of Clarification: Application Types for PA-18-794, AHRQ Small Research Grant Program (R03)
Agency for Healthcare Research and Quality - Notice of Special Interest to Highlight High Priority Research Opportunities on Suicide Prevention Crisis Services
National Institute of Mental Health
Requests for Applications
- Mechanistic Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed)
- Mechanistic Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Small Business Innovation Research on Rare Musculoskeletal, Rheumatic and Skin Diseases (SBIR) (R43 - Clinical Trial Not Allowed)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Limited Competition Cohort Studies of HIV/AIDS and Substance Abuse (U01 Clinical Trial Not Allowed)
Applications allowed only from grantees previously funded under NIDA PAR-12-222.
National Institute on Drug Abuse
- Renewal Application: Kidney Health Initiative (R18) Clinical Trials Optional
Food and Drug Administration
Program Announcements
- NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)
National Institute on Drug Abuse
- NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional)
National Institute on Drug Abuse
- NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed)
National Eye Institute
- Chemical Screening and Optimization Facility (X01 Clinical Trial Not Allowed)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at 335-2123, or email Lynn Hudachek at lynn-hudachek @uiowa.edu, or Erin Brothers at erin-brothers@uiowa.edu